| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,022 |
4,983 |
$173K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,846 |
18,264 |
$119K |
| 99233 |
Prolong inpt eval add15 m |
8,553 |
2,127 |
$77K |
| 93000 |
|
15,672 |
15,633 |
$75K |
| 99223 |
Prolong inpt eval add15 m |
1,924 |
1,827 |
$27K |
| 36482 |
|
60 |
60 |
$25K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,145 |
1,923 |
$20K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
892 |
182 |
$14K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
616 |
422 |
$11K |
| 93015 |
|
762 |
527 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
444 |
438 |
$7K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
681 |
634 |
$5K |
| 93970 |
|
271 |
270 |
$4K |
| 93880 |
|
561 |
560 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,455 |
1,413 |
$3K |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
695 |
450 |
$2K |
| 93016 |
|
158 |
155 |
$2K |
| 93018 |
|
157 |
154 |
$2K |
| 93925 |
|
479 |
477 |
$2K |
| 1159F |
|
157 |
142 |
$277.26 |
| 99497 |
|
23 |
23 |
$269.68 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,343 |
1,188 |
$224.92 |
| J2785 |
Injection, regadenoson, 0.1 mg |
44 |
44 |
$174.99 |
| 93930 |
|
546 |
546 |
$172.65 |
| 99152 |
|
13 |
13 |
$127.60 |
| 36410 |
|
407 |
350 |
$126.01 |
| 1036F |
|
6,443 |
6,259 |
$57.41 |
| 97802 |
|
16 |
16 |
$55.52 |
| 1160F |
|
157 |
142 |
$37.50 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
33 |
33 |
$26.51 |
| G8539 |
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment |
61 |
61 |
$0.08 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
279 |
278 |
$0.07 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
38 |
38 |
$0.03 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
946 |
927 |
$0.02 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
13 |
13 |
$0.01 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
4,145 |
4,094 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
64 |
63 |
$0.00 |
| 3078F |
|
14 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
4,314 |
4,260 |
$0.00 |
| 3008F |
|
48 |
37 |
$0.00 |
| 3074F |
|
15 |
12 |
$0.00 |